Isoniazid Linked to Sulfonate Esters via Hydrazone Functionality: Design, Synthesis, and Evaluation of Antitubercular Activity

Isoniazid Linked to Sulfonate Esters via Hydrazone Functionality: Design, Synthesis, and Evaluation of Antitubercular Activity

Isoniazid (INH) is one of the key molecules employed in the treatment of tuberculosis (TB), the most deadly infectious disease worldwide. However, the efficacy of this cornerstone drug has seriously decreased due to emerging INH-resistant strains of <i>Mycobacterium tuberculosis</i> (<...

Full description

Bibliographic Details
Main Authors:	Ebru Koçak Aslan, Muhammed İhsan Han, Vagolu Siva Krishna, Rasoul Tamhaev, Cagatay Dengiz, Şengül Dilem Doğan, Christian Lherbet, Lionel Mourey, Tone Tønjum, Miyase Gözde Gündüz
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	Pharmaceuticals
Subjects:	antimycobacterial <i>Mycobacterium tuberculosis</i> drug-resistant clinical isolates molecular modeling InhA
Online Access:	https://www.mdpi.com/1424-8247/15/10/1301

Similar Items

Synthesis, Biological Evaluation and Computational Studies of New Hydrazide Derivatives Containing 1,3,4-Oxadiazole as Antitubercular Agents
by: Daniele Zampieri, et al.
Published: (2022-12-01)

Isoniazid resistance profile in rifampicin resistant Mycobacterium tuberculosis
by: Naomee Shareef, et al.
Published: (2023-09-01)

Design and Synthesis of Highly Active Antimycobacterial Mutual Esters of 2-(2-Isonicotinoylhydrazineylidene)propanoic Acid
by: Václav Pflégr, et al.
Published: (2021-12-01)

Change in prevalence and molecular characteristics of isoniazid-resistant tuberculosis over a 10-year period in China
by: Fengmin Huo, et al.
Published: (2019-08-01)

Computational approach to understanding the mechanism of action of isoniazid, an anti-TB drug
by: Lingaraja Jena, et al.
Published: (2014-01-01)

Recent Advances in Anti-Tuberculosis Drug Discovery Based on Hydrazide–Hydrazone and Thiadiazole Derivatives Targeting InhA
by: Yoanna Teneva, et al.
Published: (2023-03-01)

In vitro modeling of isoniazid resistance mechanisms in Mycobacterium tuberculosis H37Rv
by: Thanadon Dokrungkoon, et al.
Published: (2023-07-01)

Integrative utility of long read sequencing-based whole genome analysis and phenotypic assay on differentiating isoniazid-resistant signature of Mycobacterium tuberculosis
by: Ming-Chih Yu, et al.
Published: (2021-12-01)

Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor
by: María Martínez-Hoyos, et al.
Published: (2016-06-01)

Contribution of katG, ahpC and inhA mutations to the detection of isoniazid-resistant Mycobacterium tuberculosis isolates from Lebanon and Syria
by: F Dabboussi, et al.
Published: (2015-01-01)

Isoniazid resistance-conferring mutations are associated with highly variable phenotypic resistance
by: Senamile Lale Ngema, et al.
Published: (2023-12-01)

N-[2-(1H-Indol-3-yl)-1-(5-thioxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)ethyl]-4-methylbenzenesulfonamide
by: Nikil Purushotham, et al.
Published: (2018-07-01)

Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic
by: Jainagul Isakova, et al.
Published: (2018-03-01)

Synthesis and antitubercular activity of isoniazid condensed with carbohydrate derivatives
by: Sílvia H. Cardoso, et al.
Published: (2009-01-01)

Identification and validation of the mode of action of the chalcone anti-mycobacterial compounds
by: B. Anagani, et al.
Published: (2020-12-01)

Insilico Analysis of Phytoconstituents from Allium sativum as Potential Inhibitors of Inha in Mycobacterium tuberculosis
by: Rmaraj Kannan, et al.

Identification of Novel Inhibitor of Enoyl-Acyl Carrier Protein Reductase (InhA) Enzyme in <i>Mycobacterium tuberculosis</i> from Plant-Derived Metabolites: An In Silico Study
by: Kratika Singh, et al.
Published: (2022-08-01)

Design, Synthesis and Molecular Docking of Novel Acetophenone-1,2,3-Triazoles Containing Compounds as Potent Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors
by: Fawzia Faleh Albelwi, et al.
Published: (2022-06-01)

Single Turnover of Transient of Reactants Supports a Complex Interplay of Conformational States in the Mode of Action of <i>Mycobacterium tuberculosis</i> Enoyl Reductase
by: Leonardo Kras Borges Martinelli, et al.
Published: (2023-03-01)

Novel Quinoline-Based Thiosemicarbazide Derivatives: Synthesis, DFT Calculations, and Investigation of Antitubercular, Antibacterial, and Antifungal Activities
by: Esma Özcan, et al.
Published: (2023-10-01)

N-Substituted 2-Isonicotinoylhydrazinecarboxamides — New Antimycobacterial Active Molecules
by: Zuzana Rychtarčíková, et al.
Published: (2014-03-01)

Tailoring selective triclosan azo-adducts: Design, synthesis, and anti-mycobacterial evaluation
by: Shekhar, et al.
Published: (2023-11-01)

New InhA Inhibitors Based on Expanded Triclosan and <i>Di</i>-Triclosan Analogues to Develop a New Treatment for Tuberculosis
by: Sarentha Chetty, et al.
Published: (2021-04-01)

In Vitro Antimycobacterial Activity and Physicochemical Characterization of Diaryl Ether Triclosan Analogues as Potential InhA Reductase Inhibitors
by: Tarek S. Ibrahim, et al.
Published: (2020-07-01)

Effective pragmatic approach of diagnosis of multidrug-resistant tuberculosis by high-resolution melt curve assay
by: Sanjay Singh Negi, et al.
Published: (2018-01-01)

Target Identification of Mycobacterium tuberculosis Phenotypic Hits Using a Concerted Chemogenomic, Biophysical, and Structural Approach
by: Grace Mugumbate, et al.
Published: (2017-09-01)

Synthesis, Biological Evaluation and 2D-QSAR Study of Halophenyl Bis-Hydrazones as Antimicrobial and Antitubercular Agents
by: Hatem A. Abdel-Aziz, et al.
Published: (2015-04-01)

Structural homology between 11 beta-hydroxysteroid dehydrogenase and Mycobacterium tuberculosis Inh-A enzyme: Dehydroepiandrosterone as a potential co-adjuvant treatment in diabetes-tuberculosis comorbidity
by: Israel Hernández-Bustamante, et al.
Published: (2023-01-01)

Profile of drug-resistant-conferring mutations among new and previously treated pulmonary tuberculosis cases from Aligarh region of Northern India
by: Shariq Ahmed, et al.
Published: (2018-01-01)

Influence of isoniazid on the metabolism of rifampicin on rat hepatocytes
by: Fasich Fasich, et al.
Published: (2000-06-01)

Terahertz and Raman Spectroscopic Investigation of Monohydrate Cocrystal of Antitubercular Isoniazid with Protocatechuic Acid
by: Yanhua Bo, et al.
Published: (2021-08-01)

Novel Hybrid 1,2,4- and 1,2,3-Triazoles Targeting Mycobacterium Tuberculosis Enoyl Acyl Carrier Protein Reductase (InhA): Design, Synthesis, and Molecular Docking
by: Maged A. El Sawy, et al.
Published: (2022-04-01)

Karakteristik Morfologi Mycobacterium tuberculosis yang Terpapar Obat Anti TB Isoniazid (INH) secara Morfologi
by: Widodo Widodo, et al.
Published: (2017-08-01)

Design, Synthesis and Antitubercular Activity of Certain Nicotinic Acid Hydrazides
by: Wagdy M. Eldehna, et al.
Published: (2015-05-01)

Navigating the Chemical Space of ENR Inhibitors: A Comprehensive Analysis
by: Vid Kuralt, et al.
Published: (2024-03-01)

Binding Thermodynamics and Dissociation Kinetics Analysis Uncover the Key Structural Motifs of Phenoxyphenol Derivatives as the Direct InhA Inhibitors and the Hotspot Residues of InhA
by: Qianqian Zhang, et al.
Published: (2022-09-01)

Treatment outcomes for isoniazid-resistant tuberculosis under program conditions in British Columbia, Canada
by: Kamila Romanowski, et al.
Published: (2017-09-01)

Facing Antitubercular Resistance: Identification of Potential Direct Inhibitors Targeting InhA Enzyme and Generation of 3D-pharmacophore Model by in silico Approach
by: EL Haddoumi G, et al.
Published: (2023-04-01)

Drug resistance-related mutations in multidrug-resistant Mycobacterium tuberculosis isolates from diverse geographical regions
by: Senia Rosales-Klintz, et al.
Published: (2012-01-01)

A bioactive implant combining isoniazid with nanohydroxyapatite/polyamide 66 for the treatment of osteoarticular tuberculosis
by: Tianhang Xie, et al.
Published: (2021-11-01)